Company Announcements

2020 Annual Report & AGM documents

Source: RNS
RNS Number : 7745I
UDG Healthcare Public Limited Co.
16 December 2020
 

UDG HEALTHCARE PLC

 

2020 Annual Report, Notice of Annual General Meeting and Form of Proxy

 

 

16 December 2020

 

 

UDG Healthcare plc (the "Company") announces that its Annual Report for the year ended

30 September 2020, together with the 2021 Notice of Annual General Meeting and Form of Proxy have been issued to shareholders.

 

Copies of these documents are available to view on the Company's website at www.udghealthcare.com.

 

The above documents have also being submitted to the U.K. National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Public Health Guidelines and the Annual General Meeting

In light of the Irish Government's Covid-19 restrictions in relation to public gatherings, and to prioritise the health and safety of our shareholders and other stakeholders who would ordinarily chose to attend the meeting, the Board of UDG have decided that the Annual General Meeting (and the subsequent Extraordinary General Meeting) will be held at our head office at 20 Riverwalk, Citywest Business Campus, Citywest, Dublin 24 D24 NR23, with the minimum quorum in accordance with the Articles of Association of the Company.

 

Shareholders are requested not to attend the meeting in person but are encouraged to participate in the meeting electronically (details of how to join the meeting electronically are contained in the Notice of Annual General Meeting) and to submit a Form of Proxy to ensure they can vote and be represented at the Meeting. Instructions on how to appoint a proxy are set out in the notes to the Notice of AGM and on the Form of Proxy.

 

For further information, please contact:

 

Damien Moynagh

General Counsel & Company Secretary

Tel: + 353-1-468-9000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKPBPCBDDNBD